| 1. |
郝南亞, 吳夢倩, 周東, 等. 中國西部女性癲癇患者妊娠及用藥數據庫的建立與實施. 癲癇雜志, 2016, 2(2): 114-117.
|
| 2. |
Schoretsanitis G, Deligiannidis KM, Kasperk N, et al. The impact of pregnancy on the pharmacokinetics of antiseizure medications: a systematic review and meta-analysis of data from 674 pregnancies. Prog Neuropsychopharmacol Biol Psychiatry, 2024, 13: 111030.
|
| 3. |
Voinescu PE, Park S, Chen LQ, et al. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy. Neurology, 2018, 91(13): e1228-e1236.
|
| 4. |
Battino D, Tomson T, Bonizzoni E, et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia, 2013, 54(9): 1621-1627.
|
| 5. |
Petrenaite V, Sabers A, Hansen-Schwartz J. Seizure deterioration in women treated with oxcarbazepine during pregnancy. Epilepsy Res, 2009, 84(2-3): 245-249.
|
| 6. |
Myllynen P, Pienim?ki P, Jouppila P, et al. Transplacental passage of oxcarbazepine and its metabolites in vivo. Epilepsia, 2001, 42(11): 1482-1485.
|
| 7. |
Wei LY, Xu ZY, Lai ZZ, et al. Association of oxcarbazepine concentration with seizure frequency in pregnant women with epilepsy. Epilepsy Behav Rep, 2023, 25: 100640.
|
| 8. |
Watila MM, Beida O, Kwari S, et al. Seizure occurrence, pregnancy outcome among women with active convulsive epilepsy: one year prospective study. Seizure, 2015, 26: 7-11.
|
| 9. |
Thomas SV, Syam U, Devi JS, et al. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia, 2012, 53(5): e85-88.
|
| 10. |
Taub?ll E, Sveberg L, Svalheim S. Interactions between hormones and epilepsy. Seizure, 2015, 28: 3-11.
|
| 11. |
Li Q, Zhang Z, Fang J. Hormonal changes in women with epilepsy. Neuropsychiatr Dis Treat, 2024, 26(20): 373-388.
|
| 12. |
Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry, 2004, 75: 1575-1583.
|
| 13. |
Wang D, Lu R, Rempala G, et al. Ligand-free estrogen receptor α (ESR1) as master regulator for the expression of CYP3A4 and other cytochrome P450 enzymes in the human liver. Mol Pharmacol, 2019, 96(4): 430-440.
|
| 14. |
Ding Y, Tan X, Li CY, et al. Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy. Brain Behav, 2019, 9(7): e01315.
|
| 15. |
Pennell PB, Hovinga CA. Antiepileptic drug therapy in pregnancy I: gestation-induced effects on AED pharmacokinetics. Int Rev Neurobiol, 2008, 83: 227-240.
|
| 16. |
Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology, 2003, 61(6 Suppl 2): S35-42.
|
